Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086408 · ClinicalTrials.gov registry record · NA
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03086408: Completed NA study, sponsored by Stanford University.
NCT03086408 is a NA study that has completed, run by Stanford University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03086408, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether diagnostic bronchoscopy can be safely and potentially more effectively performed without the use of tracheal intubation or a supraglottic airway, under completely unobstructed surgical conditions afforded by THRIVE: Transnasal Humidified Rapid- Insufflation Ventilatory Exchange. THRIVE provides patient's gas exchange through rapid insufflation of high-flow oxygen via specialized nasal cannula.
Interventions
- DEVICE THRIVE
- DEVICE Endotracheal tube or Supraglottic airway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-09 |
| Est. Completion | 2019-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03086408
The ClinicalTrials.gov registry entry for NCT03086408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which THRIVE is the first listed.
NCT03086408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03086408 about?
NCT03086408 is a clinical study titled "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Diagnostic Bronchoscopy". The purpose of this study is to investigate whether diagnostic bronchoscopy can be safely and potentially more effectively performed without the use of tracheal intubation or a supraglottic airway, under completely unobstructed surgical conditions afforded by THRIVE: Transnasal Humidified Rapid- Ins...
What is the current status of trial NCT03086408?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-09. Estimated completion is 2019-06-10.
What interventions are being tested in trial NCT03086408?
The interventions under investigation include: THRIVE (DEVICE), Endotracheal tube or Supraglottic airway (DEVICE).
Who is sponsoring clinical trial NCT03086408?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.